Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC
Open Access
- 27 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 80 (3) , 536-551
Abstract
Background and Aims: Tumor microenvironment (TME) heterogeneity leads to a discrepancy in survival prognosis and clinical treatment response for hepatocellular carcinoma (HCC) patients. The clinical applications of documented molecular subtypes are constrained by several issues. Approach and Results: We integrated three single-cell datasets to describe the TME landscape and identified six prognosis-related cell subclusters. Unsupervised clustering of subcluster-specific markers was performed to generate transcriptomic subtypes. The predictive value of these molecular subtypes for prognosis and treatment response was explored in multiple external HCC cohorts and the Xiangya HCC cohort. TME features were estimated using single-cell immune repertoire sequencing, mass cytometry and multiplex immunofluorescence. The prognosis-related score (PRS) was constructed based on machine learning algorithm. Comprehensive single-cell analysis described TME heterogeneity in HCC. The five transcriptomic subtypes possessed different clinical prognoses, stemness characteristics, immune landscapes and therapeutic responses. Class 1 exhibited an inflamed phenotype with better clinical outcomes, while Classes 2 and 4 were characterized by a lack of T cell infiltration. Classes 5 and 3 indicated an inhibitory tumor immune microenvironment. Analysis of multiple therapeutic cohorts suggested that Classes 5 and 3 were sensitive to ICB and targeted therapy, whereas Classes 1 and 2 were more responsive to transcatheter arterial chemoembolization treatment. Class 4 displayed resistant to all conventional HCC therapies. Three potential therapeutic agents and four targets were further identified for high-PRS HCC patients. Conclusion: Our study generated a clinically valid molecular classification to guide precision medicine in patients with HCC. ExportKeywords
This publication has 37 references indexed in Scilit:
- From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatmentCell, 2023
- Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?Seminars in Cancer Biology, 2022
- Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular CarcinomaCell, 2020
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular CarcinomaCell, 2019
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver CancerCancer Cell, 2019
- Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic ReprogrammingCell Reports, 2018
- Comprehensive and Integrative Genomic Characterization of Hepatocellular CarcinomaCell, 2017
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint BlockadeCell Reports, 2017
- Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung AdenocarcinomaCancer Cell, 2016
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013